Nature, Published online: 11 November 2026; doi:10.1038/s41586-026-11262-4
A novel therapeutic modality enforces non-native androgen receptor (AR)–p300/CBP interactions to collapse AR transcriptional programs, producing super-inhibitory, lineage-selective suppression of metastatic prostate cancer and establishing domain-alteration chimeras as a broadly applicable therapeutic strategy leveraging induced proximity.AI & ML
Domain-alteration chimeras rewire oncogenic complexes in prostate cancer
Nature News0 views
Source:https://www.nature.com/articles/s41586-026-11262-4
PreviousThe molecular basis of replication fork restart via repriming by PRIMPOLNextGlycosylation and importins liquefy the FG barrier in live nuclear pores
Related posts

Part 4 – Cybersecurity journeys: What I’d tell my younger self
0AWS Security Blog
Pixel users are getting a major Android Auto update – and it rivals Siri AI
0ZDNet

Developers have been hacking around MCP’s file-upload problem for two years. A fix is taking shape.
0The New Stack

Anthropic’s Claude Fable 5.2 built a shooter in 1 prompt — and it only took 8 hours and $550
0The New Stack

Expensive accelerators, no workload-level visibility: Introducing Amazon CloudWatch accelerated compute insights
0The New Stack

Why Nvidia gave OpenShell to the CNCF
0The New Stack